Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ELAN · against 138 other Healthcare companies of similar size
Ranked #117 of 139 · scores higher than 14% of peers
Bars: peers in each 10-point band of the growth score17 peers with a growth score of 30–39, including ELAN · Click a bar to see the companies
Mainly because of its earnings per share growth, which is weaker than most Healthcare peers.
| Metric | ELAN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 140 reported | 12.0% | 9.7% | 56% | 33% | |
| Earnings per share growthHigher is better · 103 reported | Not reported | 17.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 134 reported | 5.1% | 10.9% | 28% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 3 | 7.3B USD | 97 | 74 | |
| 112 | 8.5B USD | 37 | 28 | |
| 116 | 1.42T JPY (≈$9.6B) | 34 | 50 | |
| 117 | 13.2B USD | 33 | 30 | |
| 117 | 1.13T INR (≈$13.5B) | 33 | 61 | |
| 117 | 12.3B USD | 33 | 35 | |
| 117 | 166.5B SEK (≈$16.6B) | 33 | 49 | |
| 121 | 52.2B HKD (≈$6.7B) | 32 | 56 | |
| 122 | 10.8B USD | 31 | 35 | |
| 123 | 6.7B USD | 30 | 19 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score